News

Four students will be selected for funded fellowships which include a $4000 stipend and a one-time award of $500 for WiCell services/supplies for the lab. Funding is provided by the SCRMC and WiCell. The SURF …

SCRMC faculty member Qiang Chang is working to help people who have Rett Syndrome, a non-inherited brain disorder that causes severe impairments, typically in young girls. Chang was interviewed by Madison’s NBC15 on Feb. 16.

The first patient in a personalized multiple myeloma vaccine clinical trial at the UW Carbone Cancer Center was treated this past week. This cell-based vaccine was created at UW Health’s in-house Clinical Hematopoietic Cell Processing Laboratory (CHCPL).

Two SCRMC faculty members have projects funded through the New Investigator Program. Alexey Glukhov, PhD, assistant professor, Department of Medicine and Darcie Moore, PhD, assistant professor, Department of Neuroscience, each receive $100,000 over two years …

Using a molecule designed to overcome a roadblock formed by a common type of genetic flaw, researchers at the University of Wisconsin–Madison have made progress towards novel molecular treatments for Friedreich’s ataxia — a rare …

A team of researchers led by SCRMC member, Krishanu Saha, a professor of biomedical engineering at the University of Wisconsin–Madison, has made the fix less error-prone and published its approach today (Nov. 23, 2017) in the journal Nature Communications.

Nov. 20, 2017, marks the 10th anniversary of announcing the successful derivation of induced pluripotent stem cells from human somatic cells, published by SCRMC faculty member James Thomson, V.M.D., Ph.D., and his team in Science. …

“People who want a cure for X, Y and Z disease are going to be disappointed with the 10 years of progress,” said Dr. Tim Kamp, a UW-Madison cardiologist and co-director of the university’s Stem Cell and Regenerative Medicine Center. “But from a realistic standpoint, I think things have progressed fairly well.”

Congratulations to SCRMC faculty member Peiman Hematti, M.D., who has been appointed as co-chair of the Autoimmune Diseases and Cellular Therapy Working Committee for the Center for International Blood and Marrow Transplant Research.

The blood-brain barrier is the brain’s gatekeeper. A nearly impenetrable shield of cells, it keeps toxins and other agents that may be in circulating blood from gaining access to and harming the brain.